Active Ingredient: DESMOPRESSIN ACETATE
Proprietary Name: NOCDURNA
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.0277MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022517
Product Number: 001
Approval Date: Jun 21, 2018
Applicant Holder Full Name: FERRING PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
